Sardinia Research and Development is a biotechnology spin-off company created in 2008. Our core people have expertise in infectious diseases; immunology and virology; bacteriology; and the genomics of infectious diseases. Activities include; research, target discovery, and product design services.
Our company conducts design, manufacture and marketing of products derived from research in the field of advanced biotechnology in biomedicine.
We provide research services to both public and private organizations, as well as to national and international companies and institutions.
We develop advanced diagnostic and therapeutic products for human and veterinary diseases. We define new diagnostic markers using techniques of molecular biology, proteins and nucleic acids for emerging and re-emerging diseases and the identification of agents of communicable diseases for diagnostic or epidemiological.
We also produce veterinary vaccines and monoclonal and polyclonal antibodies, and develop bioinformatics services supporting research activities in biomedical applications.
Professor of Microbiology, Catholic University in Rome, President of the Italian Society for Microbiology
Instituto Clinico Universitario, Universidad de Valladolid, Spain, Clinic Immunologist
Università la Sapienza, Roma, Professor of Biotechnology
Dicle University Hospital, Diyarbakir, Turchia, Professor of Infectious Diseases
Virologist, Expert on Avian Influenza, SARS and other high pathogenic projects
Post-doctoral Researcher
Research Technician
Research Technician
Information Technologies and Bioinformatics
Chief Financial Officer
Administrative Assistant
Webmaster
Founder / President and Chief Operating Officer
Professor Salvatore Rubino, founder partner of SaRD, is a senior scientist from the University of Sassari with over 25 years of experience in infectious diseases with special emphasis in drug resistant bacteria and vaccine development. He has over 150 academic publications and has supervised a team of 25 microbiologists at the University of Sassari. His accomplishments include collaboration with development countries as an experts Italian Ministry of Foreign Affairs. He is a consultant for the WHO. He is the Editor in Chief of the Journal of Infection in Developing Countries (JIDC), an online free access journal devoted to improve the scientific capability of scientists from developing countries.
Founder / Scientific Executive Officer
Dr. David Kelvin, founding partner of SaRD, is a senior scientist at the University Health Netwok in Toronto Canada and a Professor at the University of Toronto. He is an internationally recognized immunologists with academic publications in Science, Nature Medicine, Nature Immunology, Journal of Experimental Medicine, and Proc. Natl Acad. Sci. His expertise in host immune responses again highly pathogenic infectious disease has recently gained world wide attention. He has several important discoveries in the pathogenesis of SARS and Avian Influenza. With funding from the National Institutes of Health he has been instrumental in developing animal models for testing of FDA vaccines against SARS, Avinan Influenza and Seasonal Influenza. He currently holds awards totalling over $2 million USD per year. Discoveries include identification of CXCL10 as a contributor of pathogenisis in human SARS infections and inhibitors of apoptotic pathways as therapeutic agents for treating avian influenza infections.
Scientific Director
Alyson Kelvin PhD, scientific director of SaRD, completed her PhD at Queen´s University in Belfast, UK in 2007 in the Department of Infection and Immunity within the Centre for Cancer Research and Cell Biology. Her PhD thesis emphasized novel drug targets for inflammatory disease and cancer. She has over 9 years experience in laboratory science leading to 5 academic publications and a European filed patent entitled Therapeutic Potential of USP17/DUB3 taken from work completed during her PhD. She member of the British Society of Biochemistry and has completed numerous training courses obtaining certificates. Dr. A. Kelvin has received many esteemed academic awards including the Dorothy Price Prize from the Irish Society of Immunology, Travel Award from the American Society of Biochemistry and Molecular Biology, Overseas Research Studentship from the Government of the UK, The Queen´s University Faculty of Medicine and Health Sciences PhD Studentship and Prize, The Ontario Government Studentship in Science and Technology and the University of Toronto Life Science Award. Currently she supervises 5 employees of the Sardinia Research and Development company SaRD.